Short‐term intervention of prediabetic subjects with the nutraceutical Eriomin® not only reduced hyperglycemia and increased blood GLP‐1 secretion but also had a significant effect on beta diversity in the intestinal colon, changes that were related to the improvement of prediabetic dysbiosis. Here, GCG is linked to Hyperglycemia.